Runs co-located hospitals and psychiatric facilities where patients can move between medical and mental health units without triggering Medicare penalties.
At a glance
- Depends onDownstream position: depends on 12 industries, supplies 5
- Scale
Runs co-located hospitals and psychiatric facilities where patients can move between medical and mental health units without triggering Medicare penalties.
What this company is and how it runs — written from structure, not news.
Universal Health Services runs 185 acute care hospitals and 340 behavioral health facilities, and what makes the structure unusual is that many of those sit on the same campus under two separately issued state licenses — one for medical care, one for psychiatric care — so a patient can move between a hospital bed and a psychiatric unit without being formally discharged and readmitted. That matters financially because Medicare penalizes hospitals for readmissions, and the on-site transfer sidesteps the external discharge step that would otherwise trigger that penalty. Adding more capacity is not simply a matter of building more rooms: each campus's psychiatric bed count is fixed at the time of state certificate-of-need approval, and any expansion requires a new state review that can take years, so when psychiatric demand outpaces the approved beds, the campus has no legal path to absorb it. A competitor trying to replicate this would need to clear a years-long certificate-of-need process, an 18-month Joint Commission accreditation cycle, and a Medicare enrollment period — and then repeat all of it for the behavioral health license on the same site — before a single patient transfer between units would be legally permissible.
How does this company make money?
For each acute care hospital stay, Medicare pays a fixed amount based on the patient's diagnosis category, called a DRG payment. For behavioral health stays, Medicaid pays a daily rate for each day a patient is in a psychiatric bed. Commercial insurers pay rates the company negotiates separately with each plan. In all three cases, the company submits a claim and recognizes the revenue when the patient is discharged.
What makes this company hard to replace?
In most markets this company serves, there is no competing integrated psychiatric facility to switch to — state certificate-of-need programs have prevented new ones from being built. If a competing operator tried to enter, it would face an 18-month Joint Commission preparation cycle and a 6-to-12-month Medicare provider enrollment wait before it could bill a single claim. Those delays mean a new entrant cannot become a real alternative quickly, even if a patient or a state Medicaid program wanted one.
What limits this company?
The number of psychiatric beds on each campus is locked in at the time the state originally approved the facility. Each bed is tied to specific room sizes, required nurse-to-patient ratios, and security setups. When demand for psychiatric beds exceeds the approved number, the campus has no legal way to add more without going back through a full state review process — which can take years. The company cannot simply build more rooms or move patients into spare space.
What does this company depend on?
The company cannot operate without state healthcare facility operating licenses covering all 525-plus locations, Joint Commission accreditation for its hospitals, active Medicare and Medicaid provider agreements, licensed psychiatric nurses and psychiatrists to staff the behavioral health units, and McKesson pharmaceutical distribution contracts to keep medications supplied.
Who depends on this company?
Medicare patients who need inpatient psychiatric care would face bed shortages in the many markets where this company controls most of the behavioral health capacity. State Medicaid programs would lose the contracted psychiatric beds they rely on for patients under involuntary commitment orders. Emergency departments across those markets would lose the transfer destinations they use when a patient needs inpatient psychiatric stabilization and cannot stay in an emergency room.
How does this company scale?
As the company adds more facilities, the cost of running licensing compliance, preparing for Joint Commission reviews, and processing Medicare billing spreads across a larger base — so those overhead costs get cheaper per location over time. What does not get cheaper or faster is adding psychiatric beds: every new behavioral health facility needs years of state regulatory approval and must recruit psychiatrists and psychiatric nurses from a labor market that has chronic shortages of both.
What external forces can significantly affect this company?
Medicare Advantage plans, which negotiate their own rates rather than paying standard government fees, are signing up more patients — which reduces the traditional Medicare reimbursement the company depends on. State Medicaid programs are shifting behavioral health payments away from per-diem rates toward capitated contracts, which changes how much the company earns per patient stay. DEA restrictions on opioid prescribing also affect how pain is managed in the acute care units.
Where is this company structurally vulnerable?
If a state behavioral health authority pulled the psychiatric license from an integrated campus — because of a staffing-ratio failure, a security-configuration violation, or a change in state certification rules — the hospital on that same site would instantly lose its on-site psychiatric transfer destination. The combined service line would collapse, and every patient transfer would revert to an external discharge and readmission, restoring exactly the Medicare penalty exposure the whole model was designed to eliminate.
Price is read as structure — trend, levels, range, peak and volatility drawn on the chart. It does not predict where price goes next.
Sign in to view price data.
Sign in1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow is this stock behaving?
Two structural conditions align: (1) a multi-year price band exists where the stock has, on at least two separated occasions, stopped declining and bounced upward, and (2) current price is back inside or just above that zone after a meaningful drawdown from peak. The retest is a real one — the stock is not at a new all-time high being measured as a low.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
What the company actually pays, and whether its own cash supports it.
Screen for this company's dividend patterns
Find other companies where the same dividend readings fire.
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company return capital?
Three capital-return observations have aligned: the most recent annual stock-repurchase outflow is large relative to operating cash flow, the dividend coverage-and-stability composite is elevated, and the 5-year average annual repurchase outflow is large relative to current market cap.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
The reported statements, read against the company's own industry.
4 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
Three observations describe a low-D&A profile alongside rising operating income: operating income has increased year-over-year across the trailing four years, EBIT is close to EBITDA in the most recent period (small D&A), and non-current assets are a large share of total assets. The composition is consistent with under-depreciation or a young asset base whose depreciation has not yet caught up.
Four observations co-occur: free cash flow positive each of the last three fiscal years, revenue increased each of the last three fiscal years, trailing-statistics OCF margin elevated, and book value increased each of the last four fiscal years. The configuration describes multi-year fundamental persistence across cash flow, top line, margin, and equity accumulation.
Is this company growing?
Three multi-year observations co-occur: revenue increased year-over-year in each of the last three fiscal years, gross profit (absolute level) increased year-over-year in each of the last four fiscal years, and net income was positive in each of the last five fiscal years. The configuration describes growth-and-profitability persistence across three different windows.
How is this stock valued?
Retained earnings are a large share of total assets; net income was positive in each of the last 5 fiscal years; shareholders' equity is in the upper part of its industry's equity-to-assets range.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Companies that share the same coordination system — how they create, deliver, or capture value.
Companies that share active interpretations — structural patterns currently present in both stocks.
CompanyGraph